Dual effect of 2-methoxyestradiol on cell cycle events in human osteosarcoma 143B cells.
Author(s) -
Justyna Gołębiewska,
Piotr Rozwadowski,
Jan Henryk Spodnik,
Narcyz Knap,
Takashi Wakabayashi,
Michał Woźniak
Publication year - 2002
Publication title -
acta biochimica polonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.452
H-Index - 78
eISSN - 1734-154X
pISSN - 0001-527X
DOI - 10.18388/abp.2002_3821
Subject(s) - 2 methoxyestradiol , cell cycle , osteosarcoma , metabolite , cell cycle checkpoint , cell growth , apoptosis , chemistry , cell , cell culture , microbiology and biotechnology , cell division , in vivo , estrogen , cancer research , biology , biochemistry , endocrinology , genetics
We have demonstrated for the first time that the steroid metabolite, 2-methoxyestradiol (2-ME) is a powerful growth inhibitor of human osteosarcoma 143 B cell line by pleiotropic mechanisms involving cell cycle arrest at two different points and apoptosis. The ability of 2-ME to inhibit cell cycle at the respective points has been found concentration dependent. 1 microM 2-ME inhibited cell cycle at G1 phase while 10 microM 2-ME caused G2/M cell cycle arrest. As a natural estrogen metabolite 2-ME is expected to perturb the stability of microtubules (MT) in vivo analogously to Taxol--the MT binding anticancer agent. Contrary to 2-ME, Taxol induced accumulation of osteosarcoma cells in G2/M phase of cell cycle only. The presented data strongly suggest two different mechanisms of cytotoxic action of 2-ME at the level of a single cell.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom